SecBot SecBot
8-K ·Filed May 15, 2026

TNDM

TANDEM DIABETES CARE INC
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001438133-26-000052
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any further C-suite departures or changes in commercial execution plans in upcoming quarters. The termination appears routine, but investors should watch for any signs of broader organizational upheaval.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.82
T+0 close · May 15, 2026 · via day close
Latest settled
+82.84%
T+60 · $23.44
Vs SPY
+78.32%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $12.82entry
  2. T+1 · 6mo ago +5.54%α +5.60% · $13.53
  3. T+5 · 6mo ago +16.73%α +15.77% · $14.97
  4. T+20 · 5mo ago +30.73%α +28.61% · $16.76
  5. T+60 · 3mo ago +82.84%α +78.32% · $23.44
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tandem Diabetes terminated EVP and Chief Commercial Officer Mark Novara without cause, effective May 18, 2026. The company emphasizes that its strategy and 2026 goals remain unchanged, suggesting the departure is isolated rather than a broader restructuring signal.

Key Facts

  • Mark Novara, EVP and Chief Commercial Officer, terminated without cause
  • Last day of employment is May 18, 2026
  • Company states strategy and 2026 goals remain unchanged

Financial Impact

No direct financial impact disclosed

Risk Factors

  • Potential disruption to sales or commercial operations
  • Further departures or organizational changes

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
59% bullish (29 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001438133-26-000052
Document: 0001438133-26-000052-index-headers.html0001438133-26-000052
Document: 0001438133-26-000052-index.html0001438133-26-000052
Document: 0001438133-26-000052.txt0001438133-26-000052

Track record

9 reports on TNDM

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $18.50 Now $18.48 +0.11% settles Nov 18
  2. Nov 16, 2026today SC 13G Neutral 4/10 Entry $20.00 Now $18.48 −7.60% settles Nov 17
  3. Nov 13, 20263d ago 8-K Bullish 5/10 Entry $20.07 to $18.48 Now $18.48 −7.92% ▼ −7.92% −6.01% vs SPY
  4. Nov 9, 20267d ago SC 13G Neutral 4/10 Entry $18.71 to $18.77 Now $18.48 −1.23% ▲ +0.32% −1.00% vs SPY
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $16.91 to $18.17 Now $18.48 +9.28% ▲ +7.45% +5.08% vs SPY
  6. Oct 27, 202620d ago 144 Neutral 2/10 Entry $19.68 to $19.79 Now $18.48 −6.10% ▲ +0.56% +0.94% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $15.80 to $16.60 Now $18.48 +16.96% ▲ +5.06% +4.52% vs SPY
  8. May 15, 202626w ago 8-K Neutral 3/10 Viewing Entry $12.82 to $13.53 Now $18.48 +44.15% ▲ +5.54% +5.60% vs SPY
  9. Apr 7, 202631w ago DEFA14A Neutral 3/10 Entry $19.35 to $19.68 Now $18.48 −4.50% ▲ +1.71% +1.13% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026